Expert Profile

Share QR code Edit Profile

Merry Markham

Clinical Professor

MD-HEMATOLOGY/ONCOLOGY | COLLEGE-MEDICINE

View:

Select
All (all in one) Research Terms and Keywords Background Publications Activities Co-Investigator Network Websites Contact

All
Research
Background
Publications
Activities
Network
Websites
Contact

Research Terms & Keywords

Research Terms

Clinical Oncology

Keywords

Cancer Communications Cervical Cancer Endometrial Cancer Gynecologic Cancer Ovarian Cancer Quality Of Care Social Media

Research Projects

Ends

Title

02-2025

A Phase II Study of Tazemetostat (EPZ-6438) in Recurrent Endometrioid/Clear Cell Carcinoma of the Ovary or Peritoneum, and Recurrent Low Grade Endometrioid Endometrial Adenocarcinoma A Phase II Study of Tazemetostat (EPZ-6438) in Recurrent Endometrioid/Clear Cell Carcinoma of the Ovary or Peritoneum, and Recurrent Low Grade Endometrioid Endometrial Adenocarcinoma

NATL INST OF HLTH NC

02-2025

NRG ONCOLOGY FOU

02-2025

A Phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in women with recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer A Phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in women with recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer

NATL INST OF HLTH NC

02-2025

A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer

NATL INST OF HLTH NC

06-2024

Florida Academic Cancer Center Alliance Seed Grants Florida Academic Cancer Center Alliance Seed Grants

SHANDS TEACHING HOSPITA

01-2024

Using Electronic Health Records from a Large Clinical Data Research Network to Understand Cancer Burden and Cancer Risks Among Transgender and Gender Nonconforming (TGNC) Individuals Using Electronic Health Records from a Large Clinical Data Research Network to Understand Cancer Burden and Cancer Risks Among Transgender and Gender Nonconforming (TGNC) Individuals

NATL INST OF HLTH NC

09-2023

A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combination of Cediranib/Olaparib in Women with Recurrent, Persistent or Metastatic Endometrial Cancer A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combination of Cediranib/Olaparib in Women with Recurrent, Persistent or Metastatic Endometrial Cancer

NATL INST OF HLTH NC

09-2023

NRG ONCOLOGY FOU

06-2021

Florida Cancer ReTOOL Program for Underrepresented Minority Students Florida Cancer ReTOOL Program for Underrepresented Minority Students

NATL INST OF HLTH NC

08-2019

Florida Minority Cancer Research and Training Center: Feasibility Studies Florida Minority Cancer Research and Training Center: Feasibility Studies

NATL INST OF HLTH NC

08-2019

A Randomized Phase II/III study of the combination of Cediranib and Olaparib compared to Cediranib or Olaparib alone, or Standard of care chemotherapy in women with recurrent platinum-resistant or -refractory ovarian, fallopian tube, or primary peritoneal A Randomized Phase II/III study of the combination of Cediranib and Olaparib compared to Cediranib or Olaparib alone, or Standard of care chemotherapy in women with recurrent platinum-resistant or -refractory ovarian, fallopian tube, or primary peritoneal

NATL INST OF HLTH NC

08-2019

NRG ONCOLOGY FOU

06-2019

A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer

NATL INST OF HLTH NC

06-2019

NRG ONCOLOGY FOU

03-2019

A RANDOMIZED PHASE II/III STUDY OF PACLITAXEL/CARBOPLATIN/METFORMIN (NSC#91485) VERSUS PACLITAXEL/CARBOPLATIN/PLACEBO AS INITIAL THERAPY FOR MEASURABLE STAGE III OR IVA, STAGE IVB, OR RECURRENT ENDOMETRIAL CANCER A RANDOMIZED PHASE II/III STUDY OF PACLITAXEL/CARBOPLATIN/METFORMIN (NSC#91485) VERSUS PACLITAXEL/CARBOPLATIN/PLACEBO AS INITIAL THERAPY FOR MEASURABLE STAGE III OR IVA, STAGE IVB, OR RECURRENT ENDOMETRIAL CANCER

NATL INST OF HLT

03-2019

NRG ONCOLOGY FOU

02-2019

ET-CTN with Phase 2 Emphasis ET-CTN with Phase 2 Emphasis

NATL INST OF HLTH NC

02-2019

ET-CTN with Phase 2 Emphasis ET-CTN with Phase 2 Emphasis

UNIV OF PITTSBURG

02-2019

NRG ONCOLOGY FOU

02-2019

NATL INST OF HLTH NC

02-2019

NRG ONCOLOGY FOU

06-2018

ASCO-sponsored cancer interest group ASCO-sponsored cancer interest group

AMER SOC FOR CLINICAL ONCOLOG

01-2018

A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects with Platinum-Resistant Recurrent Ovarian Cancer A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects with Platinum-Resistant Recurrent Ovarian Cancer

ASTEX PHARMACEUTICALS

11-2012

FIQCC-P03 FIQCC-P03

MOFFITT CANCER CTR, H LE

06-2011

FIQCC-P02 FIQCC-P02

MOFFITT CANCER CTR, H LE

04-2010

Pain and Palliative Care Competency Training Pain and Palliative Care Competency Training

C-CHANG

08-2009

FIQCC FIQCC

MOFFITT CANCER CTR, H LE

Degrees

M.D., Medicine

University of Miami Miller School of Medicine ▪ 2001

Publications

Search Engines

Search Google Scholar for Merry Markham

OpenAlex Works Search

OpenAlex

"Proof-of-Concept of an Integrated Yoga and Psychological Intervention in Mitigating Distress Among Diverse Women With Gynecologic, Gastrointestinal, and Thoracic Cancers"

2024 ▪ Integrative Cancer Therapies

Thomas George; Deidre B. Pereira; Merry-Jennifer Markham; Elizabeth L. Kacel; Grace Ann Hanvey; Kelsey C. Bacharz; Adaixa Padrón Wilborn; Sonia Mesa; Halle McCracken; Irene M. Estores; Frederic J. Kaye; Dennie Jones;

https://openalex.org/W4403536516

Health Sciences > Medicine > Oncology
Health Sciences > Medicine > Pediatrics, Perinatology and Child Health
Health Sciences > Medicine > Public Health, Environmental and Occupational Health
"Effects of a yoga intervention on distress indicators among diverse women with gynecologic, gastrointestinal, and thoracic cancers."

2022 ▪ Journal of Clinical Oncology

Deidre B. Pereira; Adaixa Padron; Merry-Jennifer Markham; Elizabeth L. Kacel; Grace Ann Hanvey; Kelsey C. Bacharz; Sonia Mesa; Irene M. Estores; Frederic J. Kaye; Dennie Jones;

https://openalex.org/W4281708995

Health Sciences > Medicine > Oncology
Social Sciences > Social Sciences > Sociology and Political Science
"Feasibility and acceptability of a yoga intervention for distress in women with gynecologic, gastrointestinal, or thoracic cancer."

2022 ▪ Journal of Clinical Oncology

Deidre B. Pereira; Adaixa Padron; Merry-Jennifer Markham; Elizabeth L. Kacel; Grace Ann Hanvey; Kelsey C. Bacharz; Sonia Mesa; Irene M. Estores; Frederic J. Kaye; Dennie Jones;

https://openalex.org/W4281636511

Health Sciences > Medicine > Complementary and alternative medicine
Health Sciences > Medicine > Oncology
"Characterization and Immunotherapeutic Implication of a Novel Cerebro-Spinal Fluid-Derived ALK-Positive Anaplastic Large Cell Lymphoma Cell Line"

2012 ▪ Blood

Lung-Ji Chang; Lijun Yang; Westley H Reeves; Shuhong Han; B A Gray; Hai Wang; Merry-Jennifer Markham;

https://openalex.org/W2979620276

Health Sciences > Medicine > Neurology
Health Sciences > Medicine > Oncology
Health Sciences > Medicine > Pathology and Forensic Medicine
"Hepatitis B Reactivation and Rituximab in the Oncology Practice"

2010 ▪ The Oncologist

D. R. Nelson; Thomas George; Merry-Jennifer Markham; Jeryl Villadolid; Kourtney D. LaPlant;

https://openalex.org/W2117006681

Health Sciences > Medicine > Epidemiology
Health Sciences > Medicine > Hepatology
Health Sciences > Medicine > Oncology

Memberships

American Society of Clinical Oncology, Member; 2005 - present

Co-Investigator Network

Inactive Expert

Linda Behar-Horenstein

Distinguished Teaching Scholar/Prof

University of Florida

PH-PHARMTHERAPY TRNSL RSCH, College-Pharmacy

Lsbhoren@ufl.edu

Jiang Bian

Professor and Division Director of Biomedical Informatics; Chief Data Scientist & Chief Research Information Officer, UF Health

University of Florida

MD-HOBI-BIOMED INFORMATICS, College-Medicine

bianjiang@ufl.edu

Inactive Expert

Kevin Brown

Associate Professor

University of Florida

MD-BIOCHEM / MOLECULAR BIOL, College-Medicine

kdbrown1@ufl.edu

Inactive Expert

Mary Burg

ASO PROF

University of Florida

MD-CHFM-GEN ADMINISTRATION, College-Medicine

burg@ufl.edu

Ronald Castellano

Assistant Professor

University of Florida

LS-CHEMISTRY-GENERAL, Clas

castellano@chem.ufl.edu

Linda Cottler

Dean's Professor of Epidemiology

University of Florida

PHHP-COM EPIDEMIOLOGY, Phhp-Com Integrated Programs

lbcottler@ufl.edu

Yehia Daaka

Professor

University of Florida

MD-ANATOMY, College-Medicine

ydaaka@ufl.edu

Inactive Expert

Vincent DeGennaro

University of Florida

LT-CTR-LT AMER STUDIES-ADMIN, Type One Centers

Thomas George

AssociateProfessor - Physician

University of Florida

MD-HEMATOLOGY/ONCOLOGY, College-Medicine

tgeorge@ufl.edu

Inactive Expert

Dawn Grinenko

Clinical Assistant Professor

University of Florida

MD-CHFM-GEN ADMINISTRATION, College-Medicine

grinedm@ufl.edu

Yi Guo

Associate Professor

University of Florida

MD-HOBI-GENERAL, College-Medicine

yiguo@ufl.edu

Inactive Expert

Nancy Hardt, MD

Director Health Disparities and Service Learning Programs

University of Florida

MD-PATHOLOGY-GENERAL, College-Medicine

hardt@pathology.ufl.edu

Inactive Expert

Amanda Hicks

Assistant Professor

University of Florida

DEPARTMENT OF HEALTH OUTCOMES AND BIOMEDICAL INFORMATICS, College-Medicine

aehicks@ufl.edu

Inactive Expert

Suming Huang

University of Florida

MD-BIOCHEMISTRY-GENERAL, College-Medicine

sumingh@ufl.edu

Christian Jobin

Professor of Medicine; Principal Investigator

University of Florida

MD-GASTROENTEROLOGY, College-Medicine

cjobin@ufl.edu

Frederic Kaye

Professor

University of Florida

MD-MOLECULAR GENTCS / MICROBIO, College-Medicine

fkaye@ufl.edu

Michael Kladde

Professor & Director of Center for Epigenetics

University of Florida

MD-BIOCHEM / MOLECULAR BIOL, College-Medicine

kladde@ufl.edu

Brian Law

Associate Professor

University of Florida

MD-PHARMACOLOGY / THERAPEUTICS, College-Medicine

bklaw@ufl.edu

Inactive Expert

Tanmay Lele

Faculty

University of Florida

MD-ANATOMY-GENERAL, College-Medicine

tlele@che.ufl.edu

Jonathan Licht

UF Health Cancer Center Director and The Marshall E. Rinker Senior Chair

University of Florida

MD-HEMATOLOGY/ONCOLOGY-ONCOL, College-Medicine

jdlicht@ufl.edu

Debra Lyon

Professor and Kirbo Endowed Chair

University of Florida

NR-BNS-BIOBEHAVORIAL NUR SCI, College-Nursing

delyon@ufl.edu

Nancy Mendenhall

Professor and Associate Chair

University of Florida

MD-RADIATION ONCOLOGY, College-Medicine

menden@shands.ufl.edu

David Nelson

Senior Vice President for Health Affairs, UF & President, UF Health

University of Florida

HA-EXECUTIVE, Office Of Health Affairs

nelsodr@ufl.edu

Walter O'Dell

Associate Professor

University of Florida

MD-RADIATION ONCOLOGY, College-Medicine

odelwg@shands.ufl.edu

Folakemi Odedina

Professor

University of Florida

PH-PHARMTHERAPY TRNSL RSCH, College-Pharmacy

fodedina@cop.ufl.edu

Mattia Prosperi

Professor and Associate Dean for AI and Innovation

University of Florida

HP-OFFICE OF THE DEAN, College-Publ Hlth / Hlth Profs

m.prosperi@ufl.edu

Rolf Renne

Professor

University of Florida

MD-MOLECULAR GENTCS / MICROBIO, College-Medicine

rrenne@ufl.edu

Carlos Rinaldi

University of Florida

EG-CHEMICAL ENGINEERING, College-Engineering

carlos.rinaldi@ufl.edu

Elias Sayour

Stop Children's Cancer/Bonnie R. Freeman Professor for Pediatric Oncology Research; Assistant Dean

University of Florida

MD-NEUROLOGICAL SURGERY, College-Medicine

elias.sayour@neurosurgery.ufl.edu

Richard Segal

PROF & CHR

University of Florida

PH-PHARM OUTCOMES & POLICY, College-Pharmacy

segal@cop.ufl.edu

Elizabeth Shenkman

Professor and Chair

University of Florida

MD- Health Outcomes and Policy, College-Medicine

eas@ichp.ufl.edu

Dietmar Siemann

Professor; Associate Director for Education and Training, UFHCC

University of Florida

MD-RADIATION ONCOLOGY, College-Medicine

siemadw@ufl.edu

Inactive Expert

Lindsay Thompson

Professor and Medical Director, Pediatric Research Hub

University of Florida

MD-PEDS-ADMINISTRATION, College-Medicine

lathompson@peds.ufl.edu

Inactive Expert

Jose Trevino

Associate Professor

University of Florida

MD-SURGERY-SURGONC-PBS, College-Medicine

trevinojg@ufl.edu

Diana Wilkie

Professor; Prairieview Trust ? Earl and Margo Powers Endowed Professor; Director, Center for Palliative Care Research & Education; Director, Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center

University of Florida

NR-BNS-BIOBEHAVORIAL NUR SCI, College-Nursing

diwilkie@ufl.edu

Yonghui Wu

Associate Professor & Director Of Natural Language Processing

University of Florida

MD-HOBI-BIOMED INFORMATICS, College-Medicine

yonghui.wu@ufl.edu

Lusine Yaghjyan

Associate Professor

University of Florida

PHHP-COM EPIDEMIOLOGY, Phhp-Com Integrated Programs